Liquid chromatography tandem mass spectrometry determination of selected synthetic cathinones and two piperazines in oral fluid. Cross reactivity study with an on-site immunoassay device

Journal of Chromatography A

Volumn 1374, Issue , 2014, Pages 93-101

  de Castro, Ana ^a   Lendoiro, Elena ^a   Fernández Vega, Hadriana ^a   Steinmeyer, Stefan ^b   López Rivadulla, Manuel ^a   Cruz, Angelines ^a  

^a UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

^b Architecture of Drägerwerk AG and Co KGaA   (Germany)

Author keywords

Immunoassay cross reactivity; LC MS MS; Oral fluid; Synthetic cathinone; Synthetic piperazine

Indexed keywords

DRUG PRODUCTS; EXTRACTION; IMMUNOLOGY; MASS SPECTROMETRY;

CATHINONE; CROSS REACTIVITY; LC-MS/MS; ORAL FLUIDS; SYNTHETIC PIPERAZINE;

LIQUID CHROMATOGRAPHY;

(3 CHLOROPHENYL)PIPERAZINE; 3 TRIFLUOROMETHYLPHENYLPIPERAZINE; 3,4 METHYLENEDIOXYPYROVALERONE; 4' METHYLMETHCATHINONE; ACETONITRILE; CATHINONE; FLUOROMETHAMPHETAMINE; FLUOROMETHCATHINONE; FORMIC ACID; METHEDRONE; METHYLONE; PIPERAZINE DERIVATIVE; UNCLASSIFIED DRUG; ALKALOID;

ARTICLE; BODY FLUID; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CROSS REACTION; DRUG DETERMINATION; HUMAN; IMMUNOASSAY ANALYZER; LIMIT OF DETECTION; LIMIT OF QUANTITATION; LIQUID CHROMATOGRAPHY; ORAL FLUID; PHYSICAL PHASE; SEPARATION TECHNIQUE; TANDEM MASS SPECTROMETRY; CALIBRATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IMMUNOASSAY; PROCEDURES; SYNTHESIS;

ALKALOIDS; CALIBRATION; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CROSS REACTIONS; HUMANS; IMMUNOASSAY; PIPERAZINES; TANDEM MASS SPECTROMETRY;

EID: 84916219654     PISSN: 00219673     EISSN: 18733778     Source Type: Journal    
DOI: 10.1016/j.chroma.2014.11.024     Document Type: Article

References (25)

1. Rosenbaum C.D., Carreiro S.P., Babu K.M. Here today, gone tomorrow... and back again? A review of herbal marijuana aternatives (K2, spice), synthetic cathinones (bath salts), kratom, Salvia divinorum, methoxetamine, and piperazines. J. Med. Toxicol. 2012, 8:15-32.
2. Zawilska J.B., Wojcieszak J. Designer cathinones - an emerging class of novel recreational drugs. Forensic Sci. Int. 2013, 231:42-53.
3. Baumann M.H., Partilla J.S., Lehner K.R. Psychoactive "bath salts": not so soothing. Eur. J. Pharmacol. 2013, 698:1-5.
4. Drug Enforcement Administration (DEA) US department of justice, schedules of controlled substances: temporary placement of three synthetic cathinones into schedule I. Fed. Regist. 2011, 76:65371-65375.
5. Drug Enforcement Administration (DEA) US department of justice, schedules of controlled substances: temporary placement of 10 synthetic cathinones into schedule I. Final order. Fed. Regist. 2014, 79:12938-12943.
6. Davies S., Wood D.M., Smith G., Button J., Ramsey J., Archer R., Holt D.W., Dargan P.I. Purchasing 'legal highs' on the internet - is there consistency in what you get?. Q. J. Med. 2010, 103:489-493.
7. Prosser J.M., Nelson L.S. The toxicology of bath salts: a review of synthetic cathinones. J. Med. Toxicol. 2012, 8:33-42.
8. Pearson J.M., Hargraves T.L., Hair L.S., Massucci C.J., Frazee C.C., Garg U., Pietak B.R. Three fatal intoxications due to methylone. J. Anal. Toxicol. 2012, 36:444-451.
9. Wood D.M., Davies S., Greene S.L., Button J., Holt D.W., Ramsey J., Dargan P.I. Case series of individuals with analytically confirmed acute mephedrone toxicity. Clin. Toxicol. 2010, 48:924-927.
10. Paul B.D., Cole K.A. Cathinone (Khat) and methcathinone (CAT) in urine specimens: a gas chromatographic-mass spectrometric detection procedure. J. Anal. Toxicol. 2001, 25:525-530.
11. Nieddu M., Burrai L., Trignano C., Boatto G. Evaluation of commercial multi-drug oral fluid devices to identify 39 new amphetamine-designer drugs. Leg. Med. 2014, 16:106-109.
12. Ellefsen K.N., Anizan S., Castaneto M.S., Desrosiers N.A., Martin T.M., Klette K.L., Huestis M.A. Validation of the only commercially available immunoassay for synthetic cathinones in urine: randox drugs of abuse V biochip array technology. Drug Test. Anal. 2014, (Epub ahead of print). 10.1002/dta.1633.
13. Vircks K.E., Mulligan C.C. Rapid screening of synthetic cathinones as trace residues and in authentic seizures using a portable mass spectrometer equipped with desorption electrospray ionization. Rapid Commun. Mass Spectrom. 2012, 26:2665-2672.
14. Spiller H.A., Ryan M.L., Weston R.G., Jansen J. Clinical experience with and analytical confirmation of "bath salts" and "legal highs" (synthetic cathinones) in the United States. Clin. Toxicol. 2011, 49:499-505.
15. Jankovics P., Varadi A., Tolgyesi L., Lohner S., Nemeth-Palotas J., Koszegi-Szalai H. Identification and characterization of the new designer drug 4-methylethcathinone (4-MEC) and elaboration of a novel liquid chromatography-tandem mass spectrometry (LC-MS/MS) screening method for seven different methcathinone analogs. Forensic Sci. Int. 2011, 210:213-220.
16. Antia U., Tingle M.D., Russell B.R. Validation of an LC-MS method for the detection and quantification of BZP and TFMPP and their hydroxylated metabolites in human plasma and its application to the pharmacokinetic study of TFMPP in humans. J. Forensic Sci. 2010, 55:1311-1318.
17. Sorensen L.K. Determination of cathinones and related ephedrines in forensic whole-blood samples by liquid-chromatography-electrospray tandem mass spectrometry. J. Chromatogr. B: Analyt. Technol. Biomed. Life Sci. 2011, 879:727-736.
18. Wohlfarth A., Weinmann W., Dresen S. LC-MS/MS screening method for designer amphetamines, tryptamines, and piperazines in serum. Anal. Bioanal Chem. 2010, 396:2403-2414.
19. Swortwood M.J., Boland D.M., DeCaprio A.P. Determination of 32 cathinone derivatives and other designer drugs in serum by comprehensive LC-QQQ-MS/MS analysis. Anal. Bioanal. Chem. 2013, 405:1383-1397.
20. Tsutsumi H., Katagi M., Miki A., Shima N., Kamata T., Nishikawa M., Nakajima K., Tsuchihashi H. Development of simultaneous gas chromatography-mass spectrometric and liquid chromatography-electrospray ionization mass spectrometric determination method for the new designer drugs, N-benzylpiperazine (BZP), 1-(3-trifluoromethylphenyl)piperazine (TFMPP) and their main metabolites in urine. J. Chromatogr. B: Analyt. Technol. Biomed. Life Sci. 2005, 819:315-322.
21. Strano-Rossi S., Anzillotti L., Castrignano E., Romolo F.S., Chiarotti M. Ultra high performance liquid chromatography-electrospray ionization-tandem mass spectrometry screening method for direct analysis of designer drugs, "spice" and stimulants in oral fluid. J. Chromatogr. A 2012, 1258:37-42.
22. Amaratunga P., Lorenz Lemberg B., Lemberg D. Quantitative measurement of synthetic cathinones in oral fluid. J. Anal. Toxicol. 2013, 37:622-628.
23. Concheiro M., de Castro A., Quintela O., Cruz A., Lopez-Rivadulla M. Determination of illicit and medicinal drugs and their metabolites in oral fluid and preserved oral fluid by liquid chromatography-tandem mass spectrometry. Anal. Bioanal. Chem. 2008, 391:2328-2329.
24. European Union Decision 2002/657/EC (17/8/2002) Commision decision of 12 August 2002 implementing Council Directive 96/23/EC concerning the performance of analytical methods and the interpretation of results. Off. J. Eur. Commun. 2002, 221:8-36.
25. Krouwer S., Rabinowitz R. How to improve estimates of imprecision. Clin. Chem. 1984, 30:290-292.